{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:16:36Z","timestamp":1794338196368,"version":"4.9.0"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Many novel genetic associations in the field of hyperuricaemia and gout have been described recently. This review discusses advances in gout genetics and their potential clinical applications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Genome-wide association studies have identified approximately 30 serum urate-associated loci, some of which represent targets for drug development in gout. Some genes implicated in initiating the inflammatory response to deposited crystals in gout flares have also been described. In addition, genetic studies have been used to understand the link between hyperuricaemia and other comorbidities, particularly cardiometabolic diseases. <jats:italic toggle=\"yes\">ABCG2<\/jats:italic> has been established as a key genetic determinant in the onset of gout, and plays a role in the progression and severity of disease. Recent pharmacogenetic studies have also demonstrated the association between <jats:italic toggle=\"yes\">ABCG2<\/jats:italic> and poor response to allopurinol, and the link between <jats:italic toggle=\"yes\">HLA-B<\/jats:italic>\n                                 <jats:sup>\n                                    \u2217\n                                 <\/jats:sup>\n                                 <jats:italic toggle=\"yes\">58:01<\/jats:italic> genotype and adverse drug reactions to allopurinol.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Advances in gout genetics have provided important molecular insights into disease pathogenesis, better characterized the pharmacogenetics of allopurinol, and raised the possibility of using genetic testing to provide personalized treatment for patients. Prospective studies are now needed to clarify whether genetic testing in gout provides further benefit when added to established clinical management.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000571","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T03:07:44Z","timestamp":1545361664000},"page":"144-151","source":"Crossref","is-referenced-by-count":24,"title":["Genetic advances in gout: potential applications in clinical practice"],"prefix":"10.1097","volume":"31","author":[{"given":"Vicky","family":"Tai","sequence":"first","affiliation":[{"name":"Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony R.","family":"Merriman","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Otago, Dunedin, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Dalbeth","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrrheum.2012.144","article-title":"The genetics of hyperuricaemia and gout","volume":"8","author":"Reginato","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"R4-20230829","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/annrheumdis-2017-212288","article-title":"Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis","volume":"77","author":"Dalbeth","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R5-20230829","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/ng.2500","article-title":"Genome-wide association analyses identify 18 new loci associated with serum urate concentrations","volume":"45","author":"K\u00f6ttgen","year":"2013","journal-title":"Nat Genet"},{"key":"R6-20230829","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13075-015-0609-2","article-title":"An update on the genetic architecture of hyperuricemia and gout","volume":"17","author":"Merriman","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"R7-20230829","doi-asserted-by":"crossref","first-page":"15501","DOI":"10.1073\/pnas.0904411106","article-title":"Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy","volume":"106","author":"Preitner","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R8-20230829","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ncomms1756","article-title":"Decreased extra-renal urate excretion is a common cause of hyperuricemia","volume":"3","author":"Ichida","year":"2012","journal-title":"Nat Commun"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/art.40110","article-title":"Population-specific resequencing associates the ATP-Binding Cassette subfamily C member 4 gene with gout in New Zealand Maori and Pacific men","volume":"69","author":"Tanner","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1038\/s41467-018-06620-4","article-title":"Large-scale whole-exome sequencing association studies identify rare functional variants influencing serum urate levels","volume":"9","author":"Tin","year":"2018","journal-title":"Nat Commun"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1093\/ndt\/gfq722","article-title":"URAT1 mutations cause renal hypouricaemia type 1 in Iraqi Jews","volume":"26","author":"Dinour","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R12-20230829","first-page":"3964","article-title":"A noncoding genetic variant maximally associated with serum urate levels is functionally linked to HNF4A-dependent PDZK1 expression","volume":"27","author":"Ketharnathan","year":"2018","journal-title":"Hum Mol Genet"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/annrheumdis-2014-205877","article-title":"Twenty-eight loci that influence serum urate levels: analysis of association with gout","volume":"75","author":"Phipps-Green","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R14-20230829","first-page":"2","article-title":"A comprehensive analysis of the association of common variants of ABCG2 with gout","volume":"7","author":"Yu","year":"2017","journal-title":"Sci Rep"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"000464","DOI":"10.1136\/rmdopen-2017-000464","article-title":"Multiple common and rare variants of ABCG2 cause gout","volume":"3","author":"Higashino","year":"2017","journal-title":"RMD Open"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/kex295","article-title":"Functional nonsynonymous variants of ABCG2 and gout risk","volume":"56","author":"Stiburkova","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R17-20230829","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1073\/pnas.0901249106","article-title":"Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout","volume":"106","author":"Woodward","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"e0147939","DOI":"10.1371\/journal.pone.0147939","article-title":"The Toll-Like Receptor 4 (TLR4) variant rs2149356 and risk of gout in European and Polynesian sample sets","volume":"11","author":"Rasheed","year":"2016","journal-title":"PLoS One"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1159\/000373960","article-title":"CARD8 rs2043211 polymorphism is associated with gout in a Chinese male population","volume":"35","author":"Chen","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"R21-20230829","first-page":"457","article-title":"Genetic variants of PPAR-gamma coactivator 1\u03b2 augment NLRP3-mediated inflammation in gouty arthritis","volume":"56","author":"Chang","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R22-20230829","first-page":"1127","article-title":"Replication of genetic association of peroxisome proliferator-activated receptor gamma-1B with gout in a New Zealand Polynesian sample set","volume":"69","author":"Shaukat","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R23-20230829","first-page":"323","article-title":"PPARGC1B: insight into the expression of the gouty inflammation phenotype: PPARGC1B and gouty inflammation","volume":"56","author":"Merriman","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R24-20230829","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/rheumatology\/kew057","article-title":"Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout","volume":"55","author":"Rasheed","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"43614","DOI":"10.1038\/srep43614","article-title":"Effects of multiple genetic loci on the pathogenesis from serum urate to gout","volume":"7","author":"Dong","year":"2017","journal-title":"Sci Rep"},{"key":"R26-20230829","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13075-015-0802-3","article-title":"Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout","volume":"17","author":"McKinney","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"R27-20230829","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00296-017-3669-6","article-title":"Investigation into the association between P2RX7 gene polymorphisms and susceptibility to primary gout and hyperuricemia in a Chinese Han male population","volume":"37","author":"Ying","year":"2017","journal-title":"Rheumatol Int"},{"key":"R28-20230829","doi-asserted-by":"crossref","first-page":"e0181685","DOI":"10.1371\/journal.pone.0181685","article-title":"Single nucleotide polymorphisms associated with P2X7R function regulate the onset of gouty arthritis","volume":"12","author":"Tao","year":"2017","journal-title":"PLoS One"},{"key":"R29-20230829","first-page":"503","article-title":"Mitochondrial function is required for extracellular ATP-induced NLRP3 inflammasome activation","volume":"161","author":"Sadatomi","year":"2017","journal-title":"J Biochem"},{"key":"R30-20230829","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/annrheumdis-2017-212416","article-title":"Mitochondrial genetic variation and gout in Maori and Pacific people living in Aotearoa New Zealand","volume":"77","author":"Gosling","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R31-20230829","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1038\/s41598-018-21425-7","article-title":"ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study","volume":"8","author":"Chung-Jen","year":"2018","journal-title":"Sci Rep"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.1038\/ncomms8041","article-title":"Genome-wide association analysis identifies three new risk loci for gout arthritis in Han Chinese","volume":"6","author":"Li","year":"2015","journal-title":"Nat Commun"},{"key":"R33-20230829","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/annrheumdis-2014-206191","article-title":"Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes","volume":"75","author":"Matsuo","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R34-20230829","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/annrheumdis-2016-209632","article-title":"GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes","volume":"76","author":"Nakayama","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R35-20230829","doi-asserted-by":"crossref","first-page":"25360","DOI":"10.1038\/srep25360","article-title":"Identification of rs671, a common variant of ALDH2, as a gout susceptibility locus","volume":"6","author":"Sakiyama","year":"2016","journal-title":"Sci Rep"},{"key":"R36-20230829","doi-asserted-by":"crossref","first-page":"j2376","DOI":"10.1136\/bmj.j2376","article-title":"Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies","volume":"357","author":"Li","year":"2017","journal-title":"BMJ"},{"key":"R37-20230829","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1136\/annrheumdis-2017-212534","article-title":"MR-PheWAS: exploring the causal effect of SUA level on multiple disease outcomes by using genetic instruments in UK Biobank","volume":"77","author":"Li","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R38-20230829","first-page":"129","article-title":"ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches","volume":"10","author":"Cleophas","year":"2017","journal-title":"Pharmgenomics Pers Med"},{"key":"R39-20230829","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/rheumatology\/kev350","article-title":"Novel dysfunctional variant in ABCG2 as a cause of severe tophaceous gout: biochemical, molecular genetics and functional analysis","volume":"55","author":"Stiburkova","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"R40-20230829","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3899\/jrheum.130870","article-title":"Joint effects of alcohol consumption and ABCG2 Q141K on chronic tophaceous gout risk","volume":"41","author":"Tu","year":"2014","journal-title":"J Rheumatol"},{"key":"R41-20230829","doi-asserted-by":"crossref","first-page":"9149","DOI":"10.3390\/ijms15059149","article-title":"Functional polymorphisms of the ABCG2 gene are associated with gout disease in the Chinese Han male population","volume":"15","author":"Zhou","year":"2014","journal-title":"Int J Mol Sci"},{"key":"R42-20230829","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13075-017-1254-8","article-title":"Population-specific association between ABCG2 variants and tophaceous disease in people with gout","volume":"19","author":"He","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"R43-20230829","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1186\/ar3356","article-title":"The SLC2A9 nonsynonymous Arg265His variant and gout: evidence for a population-specific effect on severity","volume":"13","author":"Hollis-Moffatt","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"R44-20230829","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/cpt.89","article-title":"Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response","volume":"97","author":"Wen","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"R45-20230829","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/tpj.2015.101","article-title":"ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout","volume":"17","author":"Roberts","year":"2017","journal-title":"Pharmacogenomics J"},{"key":"R46-20230829","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/rheumatology\/kex467","article-title":"Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis","volume":"57","author":"Wallace","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"R47-20230829","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/bcp.13516","article-title":"The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool","volume":"84","author":"Wright","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"R48-20230829","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1124\/dmd.111.043828","article-title":"The impact of single nucleotide polymorphisms on human aldehyde oxidase","volume":"40","author":"Hartmann","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"R49-20230829","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00296-016-3592-2","article-title":"Genomic sequencing of uric acid metabolizing and clearing genes in relationship to xanthine oxidase inhibitor dose","volume":"37","author":"Carroll","year":"2017","journal-title":"Rheumatol Int"},{"key":"R50-20230829","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1440-1797.2010.01368.x","article-title":"Interactions of urate transporter URAT1 in human kidney with uricosuric drugs","volume":"16","author":"Shin","year":"2011","journal-title":"Nephrology (Carlton)"},{"key":"R51-20230829","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B\u221758:01 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R52-20230829","doi-asserted-by":"crossref","first-page":"h4848","DOI":"10.1136\/bmj.h4848","article-title":"Use of HLA-B\u221758:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study","volume":"351","author":"Ko","year":"2015","journal-title":"BMJ"},{"key":"R53-20230829","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/1756-185X.13143","article-title":"Diagnostic utility of HLA-B\u221758:01 screening in severe allopurinol hypersensitivity syndrome: an updated systematic review and meta-analysis","volume":"20","author":"Yu","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"R54-20230829","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3899\/jrheum.151476","article-title":"Cost-effectiveness analysis for genotyping before allopurinol treatment to prevent severe cutaneous adverse drug reactions","volume":"44","author":"Ke","year":"2017","journal-title":"J Rheumatol"},{"key":"R55-20230829","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.semarthrit.2016.10.009","article-title":"The cost-effectiveness of HLA-B\u221758:01 screening to guide initial urate-lowering therapy for gout in the United States","volume":"46","author":"Jutkowitz","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"R56-20230829","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/rheumatology\/kex253","article-title":"Cost effectiveness analysis of HLA-B\u221758:01 genotyping prior to initiation of allopurinol for gout","volume":"56","author":"Plumpton","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R57-20230829","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/FPC.0000000000000147","article-title":"A human leukocyte antigen locus haplotype confers risk for allopurinol-related adverse effects in Caucasian patients with gout","volume":"25","author":"Roberts","year":"2015","journal-title":"Pharmacogenet Genomics"},{"key":"R58-20230829","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/00498250801956350","article-title":"In vitro drug-drug interaction studies with febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: plasma protein binding, identification of metabolic enzymes and cytochrome P450 inhibition","volume":"38","author":"Mukoyoshi","year":"2008","journal-title":"Xenobiotica"},{"key":"R59-20230829","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2133\/dmpk.DMPK-10-NT-040","article-title":"Benzbromarone pharmacokinetics and pharmacodynamics in different cytochrome P450 2C9 genotypes","volume":"25","author":"Uchida","year":"2010","journal-title":"Drug Metab Pharmacokinet"},{"key":"R60-20230829","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jbspin.2013.07.006","article-title":"Frequency of CYP2C9 polymorphisms in Polynesian people and potential relevance to management of gout with benzbromarone","volume":"81","author":"Roberts","year":"2014","journal-title":"Joint Bone Spine"},{"key":"R61-20230829","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","article-title":"Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study","volume":"74","author":"Kuo","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R62-20230829","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.semarthrit.2017.09.007","article-title":"Medication adherence among patients with gout: a systematic review and meta-analysis","volume":"47","author":"Scheepers","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"R63-20230829","doi-asserted-by":"crossref","first-page":"e8532","DOI":"10.1097\/MD.0000000000008532","article-title":"Adherence to gout management recommendations of Chinese patients","volume":"96","author":"Sheng","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R64-20230829","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1136\/annrheumdis-2013-203600","article-title":"Sugar-sweetened beverage consumption: a risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout","volume":"73","author":"Batt","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R65-20230829","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.gene.2012.04.064","article-title":"Significant interaction between LRP2 rs2544390 in intron 1 and alcohol drinking for serum uric acid levels among a Japanese population","volume":"503","author":"Hamajima","year":"2012","journal-title":"Gene"},{"key":"R66-20230829","doi-asserted-by":"crossref","first-page":"R177","DOI":"10.1186\/ar4366","article-title":"Association of the lipoprotein receptor-related protein 2 gene with gout and nonadditive interaction with alcohol consumption","volume":"15","author":"Rasheed","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"R67-20230829","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13075-017-1369-y","article-title":"Interaction of the GCKR and A1CF loci with alcohol consumption to influence the risk of gout","volume":"19","author":"Rasheed","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"R68-20230829","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/jhg.2016.57","article-title":"Additive composite ABCG2, SLC2A9 and SLC22A12 scores of high-risk alleles with alcohol use modulate gout risk","volume":"61","author":"Tu","year":"2016","journal-title":"J Hum Genet"},{"key":"R69-20230829","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/acr.22879","article-title":"You don\u2019t have to be a drinker to get gout, but it helps\u2019: a content analysis of the depiction of gout in popular newspapers","volume":"68","author":"Duyck","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R70-20230829","article-title":"\u2018Googling\u2019 gout: exploring perceptions about gout through a linguistic analysis of online search activities","author":"Jordan","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R71-20230829","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/annrheumdis-2011-200801","article-title":"Patient and provider barriers to effective management of gout in general practice: a qualitative study","volume":"71","author":"Spencer","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R72-20230829","doi-asserted-by":"crossref","first-page":"k3951","DOI":"10.1136\/bmj.k3951","article-title":"Evaluation of the diet wide contribution to serum urate levels: meta-analysis of population based cohorts","volume":"363","author":"Major","year":"2018","journal-title":"BMJ"},{"key":"R73-20230829","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1037\/hea0000548","article-title":"An illness by any other name: the effect of renaming gout on illness and treatment perceptions","volume":"37","author":"Petrie","year":"2018","journal-title":"Health Psychol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201903000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T06:52:01Z","timestamp":1693291921000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201903000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000571","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}